The Joseph and Lilian Sully Foundation
Analysis
The Joseph and Lilian Sully Foundation is a registered charity in England and Wales, based in Harpenden. It was registered in October 1992, 34 years ago. Its declared purposes cover general charitable purposes, education/training, the advancement of health or saving of lives and the prevention or relief of poverty, which this site groups under health and saving lives. Legally it is a charitable trust. It says it makes grants to organisations.
In the financial year ending March 2025, The Joseph and Lilian Sully Foundation reported income of £433k and spending of £863k, spending 199% of what it took in. Across the 5 years on record, from March 2021 to March 2025, income fell from £522k to £433k (-17%), an average of -4.6% a year. The sharpest change came in the year to March 2022, when income rose by 99%. Over the whole period it spent 138% of the income it received.
Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, The Joseph and Lilian Sully Foundation sits at the 82nd percentile: it is larger than about 82% of them. Against every charity in England and Wales with reported income it ranks in the 89th percentile. Charities of a similar size with the same main cause include Tissue Viability Society (TVS) (£433k), Deki Limited (£433k) and The Institute for Cancer Vaccines and Immunotherapy (£433k).
Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.
Income and spending
Where the income comes from
- Other 100%
In the charity's own words
-The relief of suffering, distress, disease and poverty among children and the provision of education assistance for children, their families and their communities.-The conservation and other activities for the preservation of Epping Forest as a public amenity-Other general charitable purposes
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Tissue Viability Society (TVS) | Leeds | £433k |
| Deki Limited | Bristol | £433k |
| The Institute for Cancer Vaccines and Immunotherapy | London | £433k |
| Lindengate | Aylesbury | £434k |